Interference in the fructosamine assay on the Technicon RA 1000 analyser S C BLAIR. G M SCHIER. lET GAN and R G MOSES From the Biochemistry Department, The Wollongong Hospital, Crown Street, Wollongong, 2500' NSW, Australia The estimation of the serum glycosylated protein (fructosamine) provides the clinician with a means of monitoring the short-term glycaemic status of diabetic patients. Because of the increasing use of the assay on automated analysers, I. 2 it is necessary to test for potential interference by common analytes. An interference study of the assay performed on the Cobas Bio analyser demonstrated minimal interference by 28 commonly encountered analytes.? However, five of these analytes produced significant interference" when this fructosamine assay was performed on the Technicon RA l(X)(J analyser." This suggested that the use of different instrumentation and/or reaction conditions may give rise to different levels of interference in this assay. The extent of interference on a modified fructosamine assay' was assessed by using analytes in concentrations similar to those previously described."
Each analyte was prepared in watcr (or carbonate buffer, pH )()·35 at 25°C in the case of bilirubin and uric acid) at a concentration II times greater than that shown in the Table. Intralipid (Vitrum. Stockholm. Sweden) was diluted with water to provide added triglyceride. A (J·I mL sample of test analyte was then added to I·(J mL of normal (non-diabetic) pooled serum, and the resulting fructosamine level determined (a). by the modified method of San-Gil.' using an RA l()(X) (Technicon, Sydney. NSW Australia). Results (a) were compared to the fructosamine value (b) obtained on 1·0 mL of pooled serum to which (J'l mL of the appropriate analyte diluent had been added. The extent of interference (a-b) was compared with the results of the interference study of Baker et ul. 2 for the Cobas Bio analyser. using the Roche standard fructosa- mine assay (F. Hoffman-La Roche. Basle, Switzerland.) ( Table) .
We found that glutathione at a serum concentration of 6·5 mmoVL (a concentration 60 times greater than that found in whole blood) exhibited considerable interference and resulted in a gross elevation in the fructosamine concentration (Table) . Haemoglobin (2,3 giL) produced a similar positive bias in the assay method of San-Gil et al,' This finding is in contrast to Baker et al.
2 who do not report such a marked interference by glutathione or haemoglobin (Table) . However, the effect of these two interfering red cell constituents is eliminated if haemolysed specimens are not assayed, as neither constituent is normally present in serum or plasma. We found that ascorbate at increased concentrations (0-57 mmoVL), caused considerable interference. elevating the determined fructosamine level by 1·63 mmoVL. In contrast to our findings, Baker et al. 1 report a negative bias by ascorbate. Interference to a lesser extent was encountered from added bilirubin, EDTA, heparin. oxalate. and cysteine. These findings are in general agreement with those of Baker et 01.
2
The difference in interference with these two assays is directly attributable to the difference in methods and instrumentation used. The instrument specifications for the RA WOO do not permit the use of optimum incubation times for the fructosamine assay.:' In the RA tOOO procedure of Baker et al. 2 The results of this study indicate the importance of performing interference studies when automating or using modified fructosamine methods.
